Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer

Annals of Surgical Oncology

Volumn 20, Issue 3 SUPPL., 2013, Pages

  Hiroshima, Yukihiko ^a   Nakamura, Fumio ^a   Miyamoto, Hiroshi ^a   Mori, Ryutaro ^a   Taniguchi, Koichi ^a   Matsuyama, Ryusei ^a   Akiyama, Hirotoshi ^a   Tanaka, Kuniya ^a   Ichikawa, Yasushi ^a   Kato, Shingo ^a   Kobayashi, Noritoshi ^a   Kubota, Kensuke ^a   Nagashima, Yoji ^a,b   Goshima, Yoshio ^a   Endo, Itaru ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DPYSL3 PROTEIN, HUMAN; MESSENGER RNA; MUSCLE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN VITRO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS; PANCREAS CANCER; REAL TIME POLYMERASE CHAIN REACTION; VERY ELDERLY; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CANCER STAGING; CELL DIFFERENTIATION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GENETICS; LIVER TUMOR; LYMPH NODE METASTASIS; METABOLISM; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84892815403     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2491-3     Document Type: Article

References (34)

1. American Cancer Society. Cancer facts and figures, 2011. http://www.cancer.org/Research/CancerFactsFigures/CancerFacts Figures/cancer-facts-figures-2011.
2. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605-17.
3. Blastik M, Plavecz E, Zalatnai A. Pancreatic carcinomas in a 60- year, institute-based autopsy material with special emphasis on metastatic pattern. Pancreas. 2011;40:478-80.
4. Morizane C, Okusaka T, Morita S, et al. Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma. Pancreas. 2011;40:415-21.
5. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9:274-85.
6. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. Collapsin- induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature. 1995;376(6540):509-14.
7. Fukada M, Watakabe I, Yuasa-Kawada J, et al. Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J Biol Chem. 2000;275:37957-65.
8. Gaetano C, Matsuo T, Thiele CJ. Identification and characterization of a retinoic acid-regulated human homologue of the unc- 33-like phosphoprotein gene (hUlip) from neuroblastoma cells. J Biol Chem. 1997;272:12195-201.
9. Arimura N, Inagaki N, Chihara K, et al. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. J Biol Chem. 2000;275:23973-80.
10. Wang LH, Strittmatter SM. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J Neurochem. 1997;69: 2261-9.
11. Gao M, Yeh PY, Lu YS, Chang WC, Kuo ML, Cheng AL. NFjB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells. Biochem Biophys Res Commun. 2008;376:283-7.
12. Mukherjee J, DeSouza LV, Micallef J, et al. Loss of collapsin response mediator protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII. Cancer Res. 2009;69:8545-54.
13. Pan SH, Chao YC, Chen HY, et al. Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients. Lung Cancer. 2010;67:93-100.
14. Shih JY, Lee YCG, Yang SC, Hong TM, Huang CYF, Yang PC. Collapsin response mediator protein-1: a novel invasionsuppressor gene. Clin Exp Metastasis. 2003;20:69-76.
15. Shih JY, Yang SC, Hong TM, et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst. 2001;93:1392-400.
16. Steeg PS. Collapsin response mediator protein-1: a lung cancer invasion suppressor gene with nerve. J Natl Cancer Inst. 2001;93: 1364-5.
17. Wu CC, Chen HC, Chen SJ, et al. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics. 2008;8:316-32.
18. Gao X, Pang J, Li LY, et al. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasissuppressor in prostate cancer. Oncogene. 2010;29:4555-66.
19. Bachelder RE, Lipscomb EA, Lin X, et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 2003;63:5230-3.
20. Catalano A, Caprari P, Rodilossi S, et al. Cross-talk between vascular endothelial growth factor and semaphorin-3a pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J. 2003;63:5230-4.
21. Rieger J, Wick W, Weller M. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia. 2003;42:379-89.
22. Müller MW, Giese NA, Swiercz JM, et al. Association of axon guidance factor semaphorin 3a with poor outcome in pancreatic cancer. Int J Cancer. 2007;121:2421-33.
23. Waraya M, Yamashita K, Katagiri H, et al. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Ann Surg Oncol. 2009;16:1231-40.
24. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: WHO Press; 2010.
25. Takagawa R, Akimoto K, Ichikawa Y, et al. High expression of atypical protein kinase c k/i in gastric cancer as a prognostic factor for recurrence. Ann Surg Oncol. 2009;17:81-8.
26. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275-92.
27. Dukes CE. The surgical pathology of rectal cancer. J Clin Pathol. 1949;2:95-8.
28. Sunderland DA. The significance of vein invasion by cancer of the rectum and sigmoid: a microscopic study of 210 cases. Cancer. 1949;2:429-37.
29. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJR, Morson BC. The clinical-significance of invasion of veins by rectal-cancer. Br J Surg. 1980;67:439-42.
30. Nagakawa Y, Aoki T, Kasuya K, Tsuchida A, Koyanagi Y. Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer. Pancreas. 2002;24:169-78.
31. Loukopoulos P, Kanetaka K, TakamuraM, Shibata T, Sakamoto M, Hirohashi S. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varyingmetastatic activity. Pancreas. 2004;29:193-203.
32. Wang YH, Gangeswaran R, Zhao XB, et al. CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. J Clin Invest. 2009;119:1604-15.
33. Quinn CC, Chen E, Kinjo TG, et al. TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone. J Neurosci. 2003;23:2815-23.
34. Pan SH, Chao YC, Hung PF, et al. The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1. J Clin Invest. 2011;121:3189-205.